|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.04 CNY | +0.84% |
|
+9.48% | -33.42% |
Shanghai Rendu Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 164.51 million compared to CNY 303.85 million a year ago. Net income was CNY 3.18 million compared to CNY 23.33 million a year ago.
Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.42% | 166M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. 
